27 min listen
Respiratory Syncytial Virus Vaccine Status Update
FromASHPOfficial
ratings:
Length:
13 minutes
Released:
Mar 18, 2022
Format:
Podcast episode
Description
A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Released:
Mar 18, 2022
Format:
Podcast episode
Titles in the series (100)
An ASHP Update on Pharmacy Workforce Well-Being through COVID-19: As an original sponsor of the National Academy of Medicine’s Action Collaborative on Clinician Well-Being and Resilience, ASHP is proud to represent pharmacy in interprofessional efforts to address this critical workforce and patient care issue. Join... by ASHPOfficial